Halozyme Therapeutics Inc. (HALO)

$ 62.83
   
  • Change Today:
    $2.02
  • 52 Week High: $70.14
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 3,186,817
  • Market Cap: $9,129m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,251.76 723.94 550.00¢ 11.1 n/a n/a n/a 0.0%
31-Dec-26 1,477.69 892.48 726.67¢ 8.4 0.3 +32% n/a 0.0%
31-Dec-27 1,680.97 1,083.81 923.50¢ 6.6 0.2 +27% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 62.83
Change Today $ 2.02
% Change 3.32 %
52 Week High $70.14
52 Week Low $42.57
Volume 3,186,817
Shares Issued 145.30m
Market Cap $9,129m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 4
Neutral 4
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Aug-2025

Time Volume / Share Price
13:52 182 @ $62.83
13:52 100 @ $62.83
13:52 100 @ $62.83
13:52 100 @ $62.83
13:52 100 @ $62.83

Top of Page